Search

everythinglearnresearchcommunity

for

Search:↓

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Compound 4 is a promising treatment for hair loss with low toxicity.

Children with frequent urination don't need extensive tests or aggressive treatments.

Methotrexate plus prednisolone had the fewest serious side effects.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Tadalafil and Finasteride may help treat aggressive melanoma.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Apremilast shows promise for several skin conditions but needs more research.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

Statins do not impact BPH and LUTS progression when combined with finasteride.

Dutasteride reduces DHT more effectively than finasteride.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.